Federal GLP-1 lawsuits alleging non-arteritic anterior ischemic optic neuropathy (NAION) injuries have also been transferred into a separate MDL for consolidation and coordination before Judge Marston, styled as IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation , MDL Case No
For example, a typical day might look like this: Breakfast: Greek yogurt with blueberries and chia seeds Mid-morning snack: Two boiled eggs with an apple Lunch: Grilled salmon with spinach and quinoa Afternoon snack: Cottage cheese with cucumber Dinner: Chicken breast with roasted broccoli and sweet potato That structure hits roughly 100 grams of protein and 30+ grams of fiber, keeps each meal small enough to be comfortable, and doesnt require anything unusual
Some studies suggest a possible link between GLP-1 drugs and higher risks of depression and anxiety
It tends to be dose-dependent and is more prominent during aggressive titration
It represents a different mechanistic approach than retatrutide, combining amylin and GLP-1 agonism rather than GLP-1, GIP, and glucagon agonism
Weight is one metric, but it is not the only one